TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
- TENAYA and LUCERNE Investigators
- University of Nevada, Reno
- Roche Products Limited UK
- Sydney Retina Clinic
- The University of Sydney
- Department of Ophthalmology
- National Yang Ming Chiao Tung University
- Department of Ophthalmology
- Chinese Academy of Medical Sciences
- University of Melbourne
- Ophthalmic Consultants of Boston
- Department of Ophthalmology and GRADE Reading Center
- University of Bonn
- Department of Ophthalmology
- Tokyo Women's Medical University
- Department of Ophthalmology and Visual Sciences
- University of Illinois at Chicago
- Genentech Incorporated
- Eye Clinic Zurich West
- Department of Ophthalmology
- University of Zurich
- Department of Ophthalmology
- Medical University of Vienna
- Cleveland Clinic Florida
- Hoffmann-La Roche Ltd
- AP-HP
- Université Paris Cité
Research output: Contribution to journal › Article › peer-review
213
Scopus
citations